Between 1990 and 1997, we performed 29 allogeneic BMTs for acute lymphoblastic leukemia (ALL) patients with HLA-identical sibs. Their median age was 31 years (range 15 to 43); there were 15 males and 14 females. The conditioning protocol was Cy-TBI (n=15), VP16-Cy-TBI(n=12), CBV (n=1) and Bu-Cy (n=1
Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy
โ Scribed by Axel R. Zander; Karel A. Dicke; Michael Keating; Lijda Vellekoop; Steven Culbert; Gary Spitzer; Mahesh Kanojia; Sundar Jagannath; Sylvia Schell; Jeane Hester; Raji Ayyar; Dhermvir Verma; Kenneth McCredie; Lester Peters; Christopher H. Poynton; Emil J Freireich
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 472 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Two adult patients with T cell acute lymphoblastic leukemia (ALL) received an intensive multiagent therapeutic regimen and failed to enter remission. Following cytoreduction with cyclophosphamide (60 mg/kg x 2) and total body irradiation (1000 rads) they underwent bone marrow transplantation. One pa
A case of porphyria cutanea terda (PCT) occurring after bone marrow transplantation (BMT) is reported. A 43-year-oid male with chronic myelogenous leukemia received an human leukocyte antigen (HLA)-identical allogeneic transplantation with T-cell depleted marrow. Because of graft rejection, a second
## Abstract We report a patient with a relapsed in bone marrow of extremities after allogeneic peripheral blood stem cell transplantation for acute lymphoblastic leukemia (ALL). The patient complained of pain in the right upper arm and left leg 15 months after transplantation. Magnetic resonance im
Between 1980 and 1988,126 patients with leukemia were treated with piperazinedione and fractionated total body irradiation (TBI) followed by allogeneic bone marrow transplantation from HLA matched siblings. Sixty-one patients had acute myelogenous leukemia, 46 acute lymphoblastic leukemia, and 19 ch